April 17, 2026
avatar-torie-bosch
First Opinion editor

This season, a new supporting character showed up on Bravo’s most unpleasant reality show, “Southern Charm.” In an early episode, one of the leads, Craig, said he uses ChatGPT for everything. When he needed to come up with costume idea for a literary character-themed party, he didn’t ask the friend he was filming with — he broke out his phone and asked his ChatGPT app by voice, not text, what he should dress as. (It suggested Jay Gatsby and Dorian Gray. Craig did not know who Dorian Gray was.)

Later in the season, he told a castmate, “I had a really good therapy session with ChatGPT the other day. I figured out why I snapped at Austen.” (Long, boring story.) “ChatGPT was like, ‘You just have to be patient with yourself,’” he said. “I cried, dude. I f****** cried talking to my phone.” He reiterated the sentiments moments later, saying, “I cried talking to a f****** robot.” This wasn’t even his first time talking about it — last summer, he told a podcast that he uses ChatGPT as a therapist while driving.

I thought about that while editing a First Opinion piece published this week. Marc Augustin, a German psychiatrist and psychotherapist, warned that if text-based generative AI can increase the risk of some mental health problems, the rise of voice-based AI will be even worse.

“The primary way humans communicate with AI is moving from typing and reading to speaking and listening. For most users, this will feel like a convenience. For vulnerable people — those prone to psychosis, mania, depression, or loneliness — it may represent a serious and unexamined risk,” Augustin writes.

Maybe someone should tell Craig.

Recommendation of the week: The documentary “Caterpillar,” now on Netflix, is one of the more viscerally upsetting movies I’ve watched. It follows an American man who travels to India for surgery to change the color of his eyes. Filmed in 2019, it raises thorny questions about medical tourism, beauty standards, and whether people should have the right to make bad decisions about their health.



Adobe

Don’t believe headlines saying that vaccine skepticism is widespread

Is half of the U.S. now skeptical of vaccines? Recent headlines are misleading — and that’s dangerous.

By David Higgins


Erectile dysfunction is more than a sexual issue

Taking erectile dysfunction seriously is critical to preventing cardiovascular disease and dementia, writes a urologist.

By Denise Asafu-Adjei


Health care is not ready for the new era of AI-enabled cyberattacks

The health care security reckoning that experts have warned about for years is finally coming.

By Andrea Downing


APStock

Medical schools must continue to teach students about structural barriers to care

Structural barriers like housing and transportation contribute to illness. Medical schools must continue to teach about them.

By Uché Blackstock


The medical AI revolution requires rethinking health care’s architecture

The first era of digital health focused on digitizing medical records. The next era will be defined by something more difficult.

By Freddy Abnousi and Celina Yong


Hosting the ‘intellectual wrestling match’ between MAHA, public health

On the 'First Opinion Podcast,' Brinda Adhikari and Tom W. Johnson bring together MAHA and public health for real conversations.

By Torie Bosch


Adobe

My brother can’t access a just-approved breakthrough drug for his rare disease

A new therapy for Hunter syndrome highlights the inequities of age-based drug approvals for rare diseases.

By Nathan Grant


STAT+ | Landmines await Vinay Prasad’s successor at the FDA

Lacking political savvy pretty much doomed Vinay Prasad at the FDA. His successor will have to make tough choices.

By Paul Knoepfler


Voice-first chatbots will exacerbate AI’s mental health threat

Many people already are experiencing serious chatbot-related psychological distress. The shift from text to voice will make it worse.

By Marc Augustin


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.